Gliwice Scientific Meetings 2009

 

Friday, 20^th November, 2009

 

9.00 - 9.10      Opening ceremony

 

2^nd Polish-German Cancer Workshop

 

Session: Molecular Epidemiology of Cancer

(K. Hemminki and J. Lubiński - chairpersons)

 

9.10 - 10.50 (Part I)

Kari Hemminki (Heidelberg, Germany): Genetic basis of familial aggregation of cancer (25')

Jan Lubiński (Szczecin, Poland): The latest advances in clinical genetics of tumors including gastric cancer (25')

Ute Hamann (Heidelberg, Germany): Search for modifiers of hereditary breast cancer risk (25')

Asta Försti (Heidelberg, Germany): Evidence for genetic basis in breast cancer survival (25')

 

10.50 - 11.10                         coffee break

 

11.10 - 13.00 (Part II)

Ewa Grzybowska (Gliwice, Poland): Molecular epidemiology of hereditary breast and ovary cancer in Silesia, clinical course of breast and ovary cancer in respect to polymorphisms of PGR and MDR1 genes (22')

Annekatrin Lukanova (Heidelberg, Germany): Pregnancy hormones and maternal cancer (22')

Dorota Butkiewicz (Gliwice, Poland): Genetic influences on survival in lung cancer (22')

Federico Canzian (Heidelberg, Germany): Genome-wide studies in cancer (22')

Krzysztof Szyfter (Poznań, Poland): Identification of laryngeal cancer-related genes using high resolution array-CGH technique (22')

 

13.00 - 14.15                         Lunch and Poster viewing

 

Session Functional Genomics in Cancer Research

(J. Hoheisel and P. Widłak - chairpersons)

 

14.15 - 16.00 (Part I)

Stefan Wiemann (Heidelberg, Germany): Modeling and testing of cell cycle regulation via the ErbB protein and miRNA network in breast cancer (22')

Aurelio Teleman (Heidelberg, Germany): Identification of a phosphatase regulating insulin signaling (22')

Marcin Szaumkessel (Poznań, Poland): Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in head and neck squamous cell carcinoma (15')

Sandra Steinbrink (Heidelberg, Germany): Title pending (22')

Joanna Polańska (Gliwice, Poland): New mathematical approaches in analyses of genomic and proteomic data (22')

 

16.00 - 16.20             coffee break

 

16.20 - 18.10 (Part II)

Barbara Jarząb (Gliwice, Poland): Thyroid carcinoma as a model for gene expression profiling of cancer (22')

Jörg Hoheisel (Heidelberg, Germany): Functional genomics and proteomics in pancreatic cancer research (22')

Jolanta Kupryjańczyk (Warszawa): Prognostic and predictive factors in ovarian cancer- results of verification of DNA microarray data (22')

Magdalena Skrzypczak, Jerzy Ostrowski (Warszawa, Poland): Potential and challenges of microarray data analyses for predicting oncogenic signaling in colon tumors (22')

Anna Fiszer-Kierzkowska (Gliwice, Poland): Molecular profiling of histopatologically normal prostate tissue adjacent to cancer (15')

Piotr Widłak (Gliwice, Poland): MALDI-TOF MS-based serum proteome pattern analysis in molecular diagnostics of breast cancer (22')

 

 

20.00 -                       Party - social event

Saturday, 21^st November, 2009

 

Session:  Bystander Mechanisms as Targets for Cancer Radiotherapy

(Carmel Mothersill and Joanna Rzeszowska - chairpersons)

 

9.00 - 11.05    (Part I)

Carmel Mothersill (Hamilton, Canada): Targeting bystander signaling and response pathways for cancer drug development (25')

Marie Boyd (Glasgow, UK): Bystander effects elicited by different radiation qualities - therapeutic opportunities? (25')

Elisabeth Schueltke (Freiburg, Germany): Synchrotron radiotherapy for human glioma: role of bystander mechanisms (25')

Mansoor Ahmed (Miami, USA): High-dose lattice radiation therapy: clinical, physics and biological perspective of bystander effects (25')

Wojciech Jurczak (Kraków, Poland): Haematologic toxicity of radioimmunotherapy (25')

 

11.05 - 11.30             coffee break

 

11.30 - 13.50 (Part II)

Colin Seymour (Hamilton, Canada): Radiation-induced bystander effects in vivo: possible novel targets (25')

James Murphy (Ballinode Sligo, Ireland): Low LET radiation and bystander factor damage to mammalian mitochondria (25')

Bruce C. McKay (Ottawa, Canada): Targeting transcription-coupled repair as an anti-cancer strategy (25')

Anna Marciniak-Czochra (Heidelberg, Germany): Characterization of the hematopoietic stem cells using mathematical models (25')

Krzysztof Puszyński (Gliwice, Poland): Crosstalk between p53 and nuclear factor-kappaB systems: pro- and anti-apoptotic functions of NF-kB (25')

Joanna Rzeszowska (Gliwice, Poland): Blood cells, can they be important in bystander effects? (15')

 

13.50 - 15.00             Lunch and poster viewing

 

15.00 - 16.15

Session: Ion Channels and Cancer

(Zbigniew Grzywna - chairperson)

Miquel Rubi (Barcelona, Spain): A thermodynamic description of active transport through channel proteins (25')

Walter Stühmer (Göttingen, Germany): A potassium channel involved in cancer (25')

Maria Mycielska (London, UK): Cloning and characterization of citrate transporter and its K regulatory component in prostate and prostate cancer (25')

 

16.15 - 16.50             Rewards and selected poster presentation

 

16.50                          Closing remarks